If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 11 - 20 of 271
Randomized COVID-19 Testing in Vulnerable Communities and Risk Tool Creation
Novel Methods For Estimating True Covid-19 Infection Rates And Progression Risks
Protocol No
IIT-MEURER-NIH-COVIDMKE
Categories
A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients With Treatment-refractory Mycobacterium Avium Complex Lung
Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
Protocol No
INF-AN2-EBO-301-MAC
Categories
Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of Safety, Tolerability, and Efficacy of Intravenous AP-SA02 as an Adjunct to Best Available Antibiotic Therapy for the Treatment of Adults With Bacteremia Due t
Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia (diSArm)
Protocol No
INF-ARMATA-DISARM
Categories
Expanded Access IND Protocol: Use of Tecovirimat (TPOXX) for Treatment of Human Orthopoxvirus Infections (CDC IND 116039, CDC IRB Protocol #6402)
TPOXX for Treatment of Human Orthopoxvirus Infections
Protocol No
INF-CDC-TPOXX-EA-IND-MONKEYPOX
Categories
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) (SANCTUARY)
Protocol No
NEPH-ALEXION-ALXN1210-202
Categories
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy
of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy (ARTEMIS - IGAN)
Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy
Protocol No
NEPH-ELMEANAWY-OMEROS2
Categories
A Pivotal Phase 3 Trial To Evaluate The Safety And Efficacy Of Clazakizumab For The Treatment Of Chronic Active Antibody-Mediated Rejection In Kidney Transplant Recipients
Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients
Protocol No
NEPH-SAAD-IMAGINE
Categories
Effects of Transcranial Direct Current Stimulation (tDCS) on Language
Effects of Transcranial Direct Current Stimulation (tDCS) on Language
Protocol No
NEURO-AHW-TDCS-LANGUAGE
Categories
A Multicenter, International, Randomized, Placebo Controlled, Double-Blind, Parallel Group And Event Driven Phase 3 Study Of The Oral Fxia Inhibitor Asundexian (BAY 2433334) For The Prevention Of Ischemic Stroke In Male And Female Participants Aged 1
A Study to Learn More About Asundexian (Also Called BAY2433334) for Prevention of Ischemic Stroke in Male and Female Participants Aged 18 Years and Older Who Already Had Such a Stroke Due to a Blood Clot That Formed Outside the Heart and Travelled to the Brain, or Temporary Stroke-like Symptoms
Protocol No
NEURO-BAYER-OCEANIC-STROKE
Categories
Effectiveness of Switching to Cladribine Tablets in Multiple Sclerosis Patients with High Disease Activity or Disease Breakthrough in a US Real-World Population (HDA Switch Study)
Cladribine Tablets in MS with High Disease Activity or Disease Breakthrough
Protocol No
NEURO-EMD-HDA-SWITCH